Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 8, 2020

Primary Completion Date

November 17, 2021

Study Completion Date

December 9, 2021

Conditions

Healthy

Interventions

BIOLOGICAL

CSL324

Sterile solution of recombinant anti G-CSF receptor monoclonal antibody for injection

DRUG

Placebo

Sterile solution of CSL324 formulation buffer for injection

Trial Locations (1)

Scientia Clinical Research Ltd, Randwick